Skip to main navigation Skip to search Skip to main content

Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies

Research output: Contribution to journalArticle

Abstract

no
Original languageEnglish
Pages (from-to)299-307
Number of pages9
JournalJournal of Infection
Volume58
Publication statusPublished - 2009

Keywords

  • batteremie
  • sepsi

Fingerprint

Dive into the research topics of 'Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies'. Together they form a unique fingerprint.

Cite this